PPARβ/δ and lipid metabolism in the heart.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbalip.2016.01.019PMID 26825692
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Untargeted metabolomics analysis of ischemia–reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats

  2017cited by this paper
• High-fat diet induces cardiomyocyte apoptosis via the inhibition of autophagy

  2016cited by this paper
• HypoxamiRs: regulators of cardiac hypoxia and energy metabolism.

  2015cited by this paper
• Targeting endoplasmic reticulum stress in insulin resistance.

  2015cited by this paper
• Palmitate Induces ER Stress and Autophagy in H9c2 Cells: Implications for Apoptosis and Adiponectin Resistance

  2015cited by this paper
• AMPK: energy sensor and survival mechanism in the ischemic heart.

  2015cited by this paper
• Ceramides - Lipotoxic Inducers of Metabolic Disorders.

  2015cited by this paper
• Cardiomyocyte lipotoxicity is mediated by Il-6 and causes down-regulation of PPARs.

  2015cited by this paper
• Activation of PPARβ/δ protects cardiac myocytes from oxidative stress-induced apoptosis by suppressing generation of reactive oxygen/nitrogen species and expression of matrix metalloproteinases.

  2015cited by this paper
• Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function

  2015cited by this paper
• PPARβ/δ attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells.

  2014cited by this paper
• PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism

  2014cited by this paper
• Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications

  2013cited by this paper
• Dissociation of Bcl-2–Beclin1 Complex by Activated AMPK Enhances Cardiac Autophagy and Protects Against Cardiomyocyte Apoptosis in Diabetes

  2013cited by this paper
• Fasting plasma triglycerides predict the glycaemic response to treatment of Type 2 diabetes by gastric electrical stimulation. A novel lipotoxicity paradigm

  2013cited by this paper
• The hypoxia-inducible microRNA cluster miR-199a∼214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation.

  2013cited by this paper
• Adiponectin knockout accentuates high fat diet-induced obesity and cardiac dysfunction: role of autophagy.

  2013cited by this paper
• Inherited Cardiomyopathies

  2012cited by this paper
• Autophagy regulates inflammation in adipocytes.

  2012cited by this paper
• Mechanisms of cell death in heart disease.

  2012cited by this paper
• Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

  2012cited by this paper
• Fatty Acid Synthase Modulates Homeostatic Responses to Myocardial Stress*

  2011cited by this paper
• Cardioprotection by Endoplasmic Reticulum Stress–Induced Autophagy

  2011cited by this paper
• Peroxisome Proliferator-Activated Receptor &bgr;/&dgr; Activation in Adult Hearts Facilitates Mitochondrial Function and Cardiac Performance Under Pressure-Overload Condition

  2011cited by this paper
• PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

  2011cited by this paper
• Induction of Cardiac Angptl4 by Dietary Fatty Acids Is Mediated by Peroxisome Proliferator-Activated Receptor &bgr;/&dgr; and Protects Against Fatty Acid–Induced Oxidative Stress

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010cited by this paper
• Peroxisome Proliferator-Activated Receptor &dgr; Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart

  2010cited by this paper
• Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor-β/δ Antagonist GSK3787

  2010cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease.

  2010cited by this paper
• Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.

  2010cited by this paper
• Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist.

  2010cited by this paper
• TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.

  2009cited by this paper
• Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging.

  2009cited by this paper
• Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation.

  2009cited by this paper
• Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPARα and PPARδ*

  2008cited by this paper
• From endoplasmic-reticulum stress to the inflammatory response

  2008cited by this paper
• A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.

  2008cited by this paper
• Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor β/δ (NR1C2) Antagonist

  2008cited by this paper
• PPAR-β/δ agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home

  2008cited by this paper
• Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonist.

  2008cited by this paper
• Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.

  2008cited by this paper
• In Vivo Activation of Peroxisome Proliferator-Activated Receptor-δ Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats

  2008cited by this paper
• Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.

  2008cited by this paper
• Inhibition of Cardiac Remodeling by Pravastatin Is Associated with Amelioration of Endoplasmic Reticulum Stress

  2008cited by this paper
• Activation of PPARδ inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts

  2007cited by this paper
• Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease.

  2007cited by this paper
• Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart

  2007cited by this paper
• NF-κB as an integrator of diverse signaling pathways

  2007cited by this paper
• AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36.

  2007cited by this paper
• The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.

  2007cited by this paper
• Peroxisome Proliferator–Activated Receptor γ Coactivator-1 (PGC-1) Regulatory Cascade in Cardiac Physiology and Disease

  2007cited by this paper
• Mitochondria and cardioprotection

  2007cited by this paper
• Role of AMP Kinase and PPARδ in the Regulation of Lipid and Glucose Metabolism in Human Skeletal Muscle*

  2007cited by this paper
• Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.

  2007cited by this paper
• Going nuclear in metabolic and cardiovascular disease.

  2006cited by this paper
• Reactive oxygen species have a causal role in multiple forms of insulin resistance

  2006cited by this paper
• Peroxisome proliferator-activated receptor δ (PPARδ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis

  2006cited by this paper
• Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice.

  2006cited by this paper
• Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

  2006cited by this paper
• PPARδ modulates lipopolysaccharide-induced TNFα inflammation signaling in cultured cardiomyocytes

  2006cited by this paper
• From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

  2006cited by this paper
• Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.

  2006cited by this paper
• PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes.

  2006cited by this paper
• Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation.

  2005cited by this paper
• Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes

  2005cited by this paper
• Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice.

  2005cited by this paper
• Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.

  2005cited by this paper
• Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

  2005cited by this paper
• Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

  2004cited by this paper
• Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women

  2004cited by this paper
• Lipids and lipoproteins in patients with type 2 diabetes.

  2004cited by this paper
• PKC-theta knockout mice are protected from fat-induced insulin resistance.

  2004cited by this paper
• Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts.

  2004cited by this paper
• Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes.

  2004cited by this paper
• Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

  2004cited by this paper
• PKC-θ knockout mice are protected from fat-induced insulin resistance

  2004cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity.

  2003cited by this paper
• PPARdelta is a very low-density lipoprotein sensor in macrophages.

  2003cited by this paper
• Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity

  2003cited by this paper
• PPARδ is a very low-density lipoprotein sensor in macrophages

  2003cited by this paper
• Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

  2003cited by this paper
• Retinoic Acid Is a High Affinity Selective Ligand for the Peroxisome Proliferator-activated Receptor β/δ*

  2003cited by this paper
• Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

  2003cited by this paper
• NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor (PPAR) &agr; and PPAR&bgr;/&dgr;, but not PPAR&ggr;, Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism

  2003cited by this paper
• Emerging roles of PPARS in inflammation and immunity

  2002cited by this paper
• Adaptation and maladaptation of the heart in diabetes: Part I: general concepts.

  2002cited by this paper
• Adaptation and Maladaptation of the Heart in Diabetes: Part II: Potential Mechanisms

  2002cited by this paper
• Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS.

  2002cited by this paper
• Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.

  2002cited by this paper
• Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart.

  2002cited by this paper
• Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.

  2002cited by this paper
• Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance.

  2001cited by this paper
• A novel mouse model of lipotoxic cardiomyopathy.

  2001cited by this paper
• Attenuation of Colon Inflammation through Activators of the Retinoid X Receptor (Rxr)/Peroxisome Proliferator–Activated Receptor γ (Pparγ) Heterodimer

  2001cited by this paper
• Differential Gene Regulation in Human Versus Rodent Hepatocytes by Peroxisome Proliferator-activated Receptor (PPAR) α

  2001cited by this paper
• Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ

  2001cited by this paper
• Left ventricular hypertrophy: pathogenesis, detection, and prognosis.

  2000cited by this paper

• Selective PPAR δ Activation and Seladelpar Efficacy in Primary Biliary Cholangitis and beyond.

  2026cites this paper
• Decoding the heart-saving power of Sanweidoukou decoction: Mitochondrial and molecular insights.

  2026cites this paper
• Bioinformatics-based study on the regulatory network of lipid metabolism-related genes and mechanisms in coronary heart disease

  2025cites this paper
• Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases

  2025cites this paper
• Exploring the biological basis for the identification of different syndromes in ischemic heart failure based on joint multi-omics analysis

  2025cites this paper
• GADD45A suppression contributes to cardiac remodeling by promoting inflammation, fibrosis and hypertrophy

  2025cites this paper
• METTL14 and WTAP play a crucial role in the regulation of bovine preadipocyte differentiation

  2025cites this paper
• The Role of Oxidative Stress and Inflammatory Parameters in Heart Failure

  2024cites this paper
• GATAD1 is involved in sphingosylphosphorylcholine-attenuated myocardial ischemia-reperfusion injury by modulating myocardial fatty acid oxidation and glucose oxidation.

  2024cites this paper
• PPARβ/δ prevents inflammation and fibrosis during diabetic cardiomyopathy.

  2024influential citation
• Effect of His Bundle Pacing on Abnormal Myocardial Fatty Acid and Glucose Metabolism Induced by Right Ventricular Pacing

  2024cites this paper
• Brain nuclear receptors and cardiovascular function

  2023cites this paper
• Minor alleles of FTO rs9939609 and rs17817449 polymorphisms confer a higher risk of type 2 diabetes mellitus and dyslipidemia, but not coronary artery disease in a Chinese Han population

  2023cites this paper
• Moxibustion enables protective effects on rheumatoid arthritis-induced myocardial injury transforming growth factor beta1 signaling and metabolic reprogramming.

  2023cites this paper
• Pathogenesis of obesity-associated cardiovascular diseases: key role of biomolecules

  2023cites this paper
• The contribution of mango fruit (Mangifera indica L.) to human nutrition and health

  2023cites this paper
• Comparison of Metabolic Differences between Two Geometrical Isomers Based on Multi-Omics Strategy

  2023cites this paper
• The dynamic interplay between cardiac mitochondrial health and myocardial structural remodeling in metabolic heart disease, aging, and heart failure

  2023cites this paper
• Combined metabolomic and transcriptomic profiling approaches reveal the cardiac response to high-fat diet

  2022cites this paper
• Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds

  2022cites this paper
• Metabolic reprogramming of immune cells in pancreatic cancer progression.

  2022cites this paper
• The Role of Mitochondria in Metabolic Syndrome–Associated Cardiomyopathy

  2022cites this paper
• Small molecule-mediated rapid maturation of human induced pluripotent stem cell-derived cardiomyocytes

  2022cites this paper
• Fatty Acid Metabolism and T Cells in Multiple Sclerosis

  2022influential citation
• Potential molecular mechanism of the Xiexin capsule in the intervention of dyslipidemia based on bioinformatics and molecular docking.

  2022cites this paper
• PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury

  2021cites this paper
• Gene Therapy: Targeting Cardiomyocyte Proliferation to Repopulate the Ischemic Heart.

  2021cites this paper
• β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure.

  2021cites this paper
• Understanding the Multiple Effects of PCBs on Lipid Metabolism

  2020cites this paper
• Critical biomarkers for myocardial damage by fine particulate matter: Focused on PPARα-regulated energy metabolism.

  2020cites this paper
• A novel plausible mechanism of NSAIDs-induced apoptosis in cancer cells: the implication of proline oxidase and peroxisome proliferator-activated receptor

  2020cites this paper
• PPARβ/δ: Benefits in Coronary Artery Disease and Beyond

  2019cites this paper
• Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis

  2019influential citation
• The role of individual n-6 polyunsaturated fatty acids on regulating cardiovascular reactivity

  2019cites this paper
• miR‐29a attenuates cardiac hypertrophy through inhibition of PPARδ expression

  2019cites this paper
• Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder

  2019cites this paper
• PPARβ/δ: Linking Metabolism to Regeneration

  2018cites this paper
• The beneficial effects of Zn on Akt-mediated insulin and cell survival signaling pathways in diabetes.

  2018cites this paper
• Central leptin regulates heart lipid content by selectively increasing PPAR β/δ expression.

  2018cites this paper
• PPARδ, a Potential Therapeutic Target for Heart Disease

  2018cites this paper
• Inhibition of Cannabinoid Receptor 1 Can Influence the Lipid Metabolism in Mice with Diet-Induced Obesity

  2018cites this paper
• Metabolic remodeling of substrate utilization during heart failure progression

  2018cites this paper
• Influence of the Periodontal Disease, the Most Prevalent Inflammatory Event, in Peroxisome Proliferator-Activated Receptors Linking Nutrition and Energy Metabolism

  2017cites this paper
• A combined genotype of three SNPs in the bovine gene is related to growth performance in Chinese cattle

  2017cites this paper
• Untargeted metabolomics analysis of ischemia–reperfusion-injured hearts ex vivo from sedentary and exercise-trained rats

  2017cites this paper
• Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.

  2017cites this paper
• Main constituents of polyphenol complex from seagrasses of the genus Zostera, their antidiabetic properties and mechanisms of action.

  2017cites this paper
• Trimedazidine alleviates pulmonary artery banding-induced acute right heart dysfunction and activates PRAS40 in rats

  2017cites this paper
• Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives

  2016cites this paper
• Preface to the BBA special issue "heart lipid metabolism".

  2016cites this paper
• Peroxisome proliferator‐activated receptors in cardiac energy metabolism and cardiovascular disease

  2016cites this paper
• Analyse de la composition en acides gras des lipides dans la sclérose latérale amyotrophique : implications dans le processus pathologique

  2016cites this paper
• Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging.

  2016cites this paper